Send to a Friend Font Size: Increase Decrease

MGX and ALCLS Related Headlines

Jul 15, 2026 08:01AM Prolynx names CFO and CSO to advance obesity drug portfolio
Jul 15, 2026 08:00AM Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio

MGX and ALCLS Related Press Releases

Jul 15, 2026 08:00AM Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio

MGX and ALCLS Related SEC Filings